Mrv0541 02231217492D 16 17 0 0 0 0 999 V2000 1.4289 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -2.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -3.7125 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -3.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -2.8875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.8579 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5724 -2.8875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.8579 -1.6500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.5724 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5724 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0013 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0013 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 2 7 1 0 0 0 0 3 8 1 0 0 0 0 8 9 2 0 0 0 0 8 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 2 0 0 0 0 12 13 1 0 0 0 0 13 14 2 0 0 0 0 14 15 1 0 0 0 0 15 16 2 0 0 0 0 11 16 1 0 0 0 0 M END > DB04657 > drugbank > CC1=C(SCCO1)C(=O)NC1=CC=CC=C1 > InChI=1S/C12H13NO2S/c1-9-11(16-8-7-15-9)12(14)13-10-5-3-2-4-6-10/h2-6H,7-8H2,1H3,(H,13,14) > GYSSRZJIHXQEHQ-UHFFFAOYSA-N > C12H13NO2S > 235.302 > 235.066699355 > 2 > 29 > -5.704348407248996e-07 > 24.8500583388456 > 1 > 1 > 0 > 1 > 2-methyl-N-phenyl-5,6-dihydro-1,4-oxathiine-3-carboxamide > 1.65 > 1.5126589993333335 > -2.64 > 0 > 0 > 2 > 0 > 13.243224638432908 > -2.125282844764014 > 38.33 > 69.09630000000001 > 2 > 1 > 5.36e-01 g/l > biotin > 1 > DB04657 > approved; experimental > Carboxin > 2,3-Dihydro-5-carboxanilido-6-methyl-1,4-oxathiin; 2,3-Dihydro-6-methyl-1,4-oxathiin-5-carboxanilide; 2,3-Dihydro-6-methyl-5-phenylcarbamoyl-1,4-oxathiin; 5-Carboxanilido-2,3-dihydro-6-methyl-1,4-oxathiin; 5,6-Dihydro-2-methyl-1,4-oxathiin-3-carboxanilide; 5,6-Dihydro-2-methyl-3-carboxanilido-1,4-oxathiin; 5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide; Carbathiin; Carboxine; Oxatin > Kisvax; Vitavax $$$$